{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:12:23Z","timestamp":1778875943704,"version":"3.51.4"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Zenkel Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alternative insulin preparations are needed when NPH insulin is ineffective in diabetic dogs. This study evaluated the efficacy of recombinant human protamine zinc insulin (rhPZI) for treating diabetic dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis<\/jats:title>\n                    <jats:p>rhPZI is effective for treating diabetic dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Six newly diagnosed and 11 insulin-treated diabetic dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Prospective clinical trial. Dogs were treated with rhPZI for 60\u00a0days. Control of glycemia was assessed on days 7, 14, 30, and 60 by evaluation of history, physical examination, body weight, serum fructosamine concentration, and blood glucose concentrations measured before and 2, 4, 6, 8, and 10\u00a0hours after rhPZI administration. Adjustments in dosage of rhPZI were made as needed to control glycemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>rhPZI administration resulted in a significant decrease in 10-hour mean blood glucose (MBG10h; 299\u00a0\u00b1\u00a0115 versus 457\u00a0\u00b1\u00a038\u00a0mg\/dL, X\u00a0\u00b1\u00a0SD, P\u00a0= .0003) and serum fructosamine (478\u00a0\u00b1\u00a083 versus 557\u00a0\u00b1\u00a0104\u00a0\u03bcmol\/L, P\u00a0= .006) concentration at day 60, compared with day 1, respectively. By day 60, polyuria and polydipsia had improved in 14, body weight was stable or increased in 16, MBG10h had decreased in 16, and serum fructosamine concentration had decreased in 11 of 17 dogs, compared with day 1. Hypoglycemia (&amp;lt;80\u00a0mg\/dL) was the only consistent adverse event.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Relevance<\/jats:title>\n                    <jats:p>rhPZI is effective in diabetic dogs and can be considered as an alternative treatment in diabetic dogs that are poorly controlled using other insulin preparations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1939-1676.2011.00861.x","type":"journal-article","created":{"date-parts":[[2011,12,24]],"date-time":"2011-12-24T19:02:50Z","timestamp":1324753370000},"page":"109-115","source":"Crossref","is-referenced-by-count":23,"title":["Efficacy of Protamine Zinc Recombinant Human Insulin for Controlling Hyperglycemia in Dogs with Diabetes Mellitus"],"prefix":"10.1093","volume":"26","author":[{"given":"A. Della","family":"Maggiore","sequence":"first","affiliation":[{"name":"Veterinary Medical Teaching Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. W.","family":"Nelson","sequence":"additional","affiliation":[{"name":"of Medicine and Epidemiology Departments"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Dennis","sequence":"additional","affiliation":[{"name":"BluePearl Specialty and Emergency Medicine for Pets- , Kansas City, Kansas City, KS"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Surgical and Radiological Sciences, School of Veterinary Medicine, University of California , Davis, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. H.","family":"Kass","sequence":"additional","affiliation":[{"name":"Population Health and Reproduction"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,1,1]]},"reference":[{"key":"2026020303570620500_jvim861-bib-0001","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1939-1676.2005.tb02745.x","article-title":"Efficacy and safety of a purified porcine insulin zinc suspension for managing diabetes mellitus in dogs","volume":"19","author":"Monroe","year":"2005","journal-title":"J Vet Intern Med"},{"key":"2026020303570620500_jvim861-bib-0002","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1939-1676.2008.0249.x","article-title":"An investigation of the action of neutral protamine Hagedorn human analogue insulin in dogs with naturally occurring diabetes mellitus","volume":"23","author":"Palm","year":"2009","journal-title":"J Vet Intern Med"},{"issue":"1","key":"2026020303570620500_jvim861-bib-0003","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1016\/j.diabres.2010.08.011","article-title":"Distinct pharmacodynamics of insulin glargine and insulin detemir: Crossover comparison in Type 1 and Type 2 diabetic patients on basal-bolus regimen","volume":"90","author":"Kato","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"2026020303570620500_jvim861-bib-0004","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2460\/javma.2001.218.38","article-title":"Efficacy of protamine zinc insulin for treatment of diabetes mellitus in cats","volume":"218","author":"Nelson","year":"2001","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303570620500_jvim861-bib-0005","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/j.1939-1676.2008.0194.x","article-title":"Anti-insulin antibodies in diabetic dogs before and after treatment with different insulin preparations","volume":"22","author":"Davison","year":"2008","journal-title":"J Vet Intern Med"},{"key":"2026020303570620500_jvim861-bib-0006","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1939-1676.2009.0342.x","article-title":"Field safety and efficacy of protamine zinc recombinant human insulin for treatment of diabetes mellitus in cats","volume":"23","author":"Nelson","year":"2009","journal-title":"J Vet Intern Med"},{"key":"2026020303570620500_jvim861-bib-0007","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2460\/javma.235.3.276","article-title":"Evaluation of six portable blood glucose meters for measuring blood glucose concentration in dogs","volume":"235","author":"Cohen","year":"2008","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303570620500_jvim861-bib-0008","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1939-1676.1993.tb03183.x","article-title":"Fructosamine: A new parameter for diagnosis and metabolic control in diabetic dogs and cats","volume":"7","author":"Reusch","year":"1993","journal-title":"J Vet Intern Med"},{"key":"2026020303570620500_jvim861-bib-0009","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1939-165X.2010.00245.x","article-title":"Analytic validation of an ELISA for measurement of canine pancreas-specific lipase","volume":"39\/3","author":"Huth","year":"2010","journal-title":"Vet Clin Pathol"},{"key":"2026020303570620500_jvim861-bib-0010","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1748-5827.1981.tb00613.x","article-title":"The blood glucose response to three prolonged duration insulins in canine diabetes mellitus","volume":"22","author":"Church","year":"1981","journal-title":"J Small Anim Pract"},{"key":"2026020303570620500_jvim861-bib-0011","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.2460\/javma.1982.180.12.1432","article-title":"Insulin-induced hyperglycemia in diabetic dogs","volume":"180","author":"Feldman","year":"1982","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303570620500_jvim861-bib-0012","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2460\/javma.2000.216.217","article-title":"Effect of insulin dosage on glycemic response in dogs with diabetes mellitus: 221 cases (1993-1998)","volume":"216","author":"Hess","year":"2000","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303570620500_jvim861-bib-0013","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/vr.164.8.232","article-title":"Pharmacokinetics and pharmacodynamics of porcine insulin zinc suspension in eight diabetic dogs","volume":"164","author":"Fleeman","year":"2009","journal-title":"Vet Rec"},{"key":"2026020303570620500_jvim861-bib-0014","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/BF03547312","article-title":"The use of isophane insulin for the control of diabetes mellitus in dogs","volume":"33","author":"Lorenzen","year":"1992","journal-title":"Acta Vet Scand"},{"key":"2026020303570620500_jvim861-bib-0015","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2337\/diacare.23.6.813","article-title":"Pharmacokinetics of 125I-labeled insulin glargine (HOE901)in healthy men-comparison with NPH insulin and the influence of different subcutaneous injection sites","volume":"23","author":"Owens","year":"2000","journal-title":"Diabetic Care"},{"issue":"1","key":"2026020303570620500_jvim861-bib-0016","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cvsm.2009.12.001","article-title":"Insulin resistance in dogs","volume":"40","author":"Hess","year":"2010","journal-title":"Vet Clin North Am Small Anim Pract"},{"issue":"1","key":"2026020303570620500_jvim861-bib-0017","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0195-5616(95)50063-4","article-title":"Diagnosis and management of insulin resistance in dogs and cats with diabetes mellitus","volume":"25","author":"Peterson","year":"1995","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"2026020303570620500_jvim861-bib-0018","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2460\/javma.1998.212.03.380","article-title":"Effect of dietary insoluble fiber on control of glycemia in dogs with naturally acquired diabetes mellitus","volume":"212","author":"Nelson","year":"1998","journal-title":"J Am Vet Med Assoc"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1939-1676.2011.00861.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/26\/1\/109\/66683618\/jvim861.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/26\/1\/109\/66683618\/jvim861.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T08:57:18Z","timestamp":1770109038000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/26\/1\/109\/8451646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1939-1676.2011.00861.x","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,1]]},"published":{"date-parts":[[2012,1,1]]}}}